The lack of routine surveillance of parvovirus B19 infection in pregnancy prevents an accurate understanding of this regular cause of fetal loss and the risks posed by occupational exposure

Journal of Medical Microbiology

Volumn 62, Issue PART1, 2013, Pages 86-92

  Watt, Alison P ^a   Brown, Martin ^a   Pathiraja, Melanie ^a   Anbazhagan, Akila ^b   Coyle, Peter V ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASYMPTOMATIC INFECTION; CONTROLLED STUDY; DAY CARE; DISEASE SURVEILLANCE; FEMALE; FETUS WASTAGE; FOLLOW UP; HEALTH; HEALTH CARE PERSONNEL; HUMAN; HUMAN PARVOVIRUS B19; IMMUNITY; INCIDENCE; MALE; MEDICAL PRACTICE; NONHUMAN; OCCUPATIONAL EXPOSURE; PARVOVIRUS INFECTION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PUBLIC HEALTH; RISK; SEROPREVALENCE; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW (TOPIC); UNITED KINGDOM; VIRUS LOAD; VIRUS TRANSMISSION;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DNA, VIRAL; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; NORTHERN IRELAND; OCCUPATIONAL EXPOSURE; PARVOVIRUS B19, HUMAN; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEASONS; YOUNG ADULT;

EID: 84871130335     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.046714-0     Document Type: Article

References (29)

1. Adler, S. P., Manganello, A. M., Koch, W. C., Hempfling, S. H. & Best, A. M. (1993). Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 168, 361-368.
2. Beigi, R. H., Wiesenfeld, H. C., Landers, D. V. & Simhan, H. N. (2008). High rate of severe fetal outcomes associated with maternal parvovirus B19 infection in pregnancy. Infect Dis Obstet Gynecol 2008, 524601.
3. CEMACH (2007). Saving Mothers' Lives: Reviewing Maternal Deaths to Make Motherhood Safer - 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. Edited by G. Lewis. London: CEMACH.
4. de Villemeur, A. B., Gratacap-Cavallier, B., Casey, R., Baccard-Longère, M., Goirand, L., Seigneurin, J. M. & Morand, P. (2011). Occupational risk for cytomegalovirus, but not for parvovirus B19 in child-care personnel in France. J Infect 63, 457-467.
5. Doherty, L. (2008). Parvovirus B19 Infection in Pregnant Women. http://www.dhsspsni.gov.uk/hss-md-11-2008.pdf
6. Duckitt, K. & Qureshi, A. (2011). Recurrent miscarriage. Clin Evid (Online) 2011, pii: 1409.
7. ECDC (2009a). Annual Epidemiological Report on Communicable Diseases in Europe 2009. http://ecdc.europa.eu/en/publications/Publications/0910_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf. Stockholm: ECDC.
8. ECDC (2009b). Special Issue: Pregnancy and Infectious Diseases. Eurosurveillance 14, Issue 1-12, Jan-Mar 2009. http://www.eurosurveillance.org/images/dynamic/EQ/V14N01/V14N01.pdf
9. ECDC (2011). Annual Epidemiological Report 2011. Reporting on 2009 Surveillance Data and 2010 Epidemic Intelligence Data. http://www.ecdc.europa.eu/en/publications/Publications/1111_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf. Stockholm: ECDC.
10. Enders, M., Klingel, K., Weidner, A., Baisch, C., Kandolf, R., Schalasta, G. & Enders, G. (2010). Risk of fetal hydrops and nonhydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol 49, 163-168.
11. Gärtner, B., Enders, M., Luft-Duchow, C., Bocharov, G. & Modorow, S. (2007). Parvovirus B-19 infections in pregnant women in day care facilities: health economic analysis of prohibition to employ seronegative women. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50, 1369-1378 (in German).
12. Gilbert, G. L. (2000). Parvovirus B19 infection and its significance in pregnancy. Commun Dis Intell 24 (Suppl.), 69-71.
13. Gillespie, S. M., Cartter, M. L., Asch, S., Rokos, J. B., Gary, G. W., Tsou, C. J., Hall, D. B., Anderson, L. J. & Hurwitz, E. S. (1990). Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA 263, 2061-2065.
14. Harger, J. H., Adler, S. P., Koch, W. C. & Harger, G. F. (1998). Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 91, 413-420.
15. Miller, E., Fairley, C. K., Cohen, B. J. & Seng, C. (1998). Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105, 174-178.
16. Mitchell, E. (2009). Increase in Parvovirus B19 Infection -Advice on Management of Suspected Infections in Pregnancy. http://www.dhsspsni.gov.uk/hss-md-12-2009.pdf. Northern Ireland: Department of Health, Social Services and Public Safety.
17. Mossong, J., Hens, N., Friederichs, V., Davidkin, I., Broman, M., Litwinska, B., Siennicka, J., Trzcinska, A., VAN Damme, P. & other authors (2008). Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 136, 1059-1068.
18. NCCWCH (2008). Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: RCOG Press.
19. Nicolay, N. & Cotter, S. (2009). Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996-June 2008. Euro Surveill 14, 19249.
20. Oliveira, S. A., Camacho, L. A., Pereira, A. C., Faillace, T. F., Setubal, S. & Nascimento, J. P. (2002). Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil). Mem Inst Oswaldo Cruz 97, 965-970.
21. Rash Guidance Working Group (2011). Guidance on Viral Rash in Pregnancy: Investigation, Diagnosis and Management of Viral Rash Illness, or Exposure to Viral Rash Illness, in Pregnancy. London: Health Protection Agency.
22. Regan L Backos & Rai, R. (2011). The Investigation and Treatment of Couples with Recurrent First-Trimester and Second-Trimester Miscarriage. Green-Top Guideline No. 17. London: Royal College of Obstetricians and Gynaecologists.
23. Simpson, J. L. (1990). Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet 35, 165-173.
24. Skjöldebrand-Sparre, L., Tolfvenstam, T., Papadogiannakis, N., Wahren, B., Broliden, K. & Nyman, M. (2000). Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG 107, 476-480.
25. Stelma, F. F., Smismans, A., Goossens, V. J., Bruggeman, C. A. & Hoebe, C. J. (2009). Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence. Eur J Clin Microbiol Infect Dis 28, 393-397.
26. The Council Of The European Communities (1992). Council Directive 92/85/EEC of 19 October 1992 on the Introduction of Measures to Encourage Improvements in the Safety and Health at Work of Pregnant Workers and Workers who Have Recently Given Birth or Are Breastfeeding, pp. 1-8.
27. EUR-Lex. UK National Screening Committee (2010). Infectious Diseases in Pregnancy Screening Programme: Programme Standards. UK: NHS.
28. Valeur-Jensen, A. K., Pedersen, C. B., Westergaard, T., Jensen, I. P., Lebech, M., Andersen, P. K., Aaby, P., Pedersen, B. N. & Melbye, M. (1999). Risk factors for parvovirus B19 infection in pregnancy. JAMA 281, 1099-1105.
29. Watt, A., Coyle, P., Parris, C. & Vizzard, C. (2011). Audit of the management of susceptible pregnant women following exposure to parvovirus B19 Bulletin of the Royal College of Pathologists 156, 277-281.